One of IAG Cargo’s flagship premium products, Constant Climate has seen consistent double-digit volume growth year-on-year, with the carrier now transporting more than 35,000 shipments annually. The volume growth has followed the increase of global pharmaceutical sales, which passed the US$1trn mark for the first time at the end of 2014; and this is anticipated to reach US$1.3trn by 2018.
Constant Climate provides customers with precision temperature control for pharmaceuticals and life sciences, most commonly transporting critical vaccines, oncology drugs and insulin around the world. The active and passive variants of Constant Climate have the capacity to support temperature-specific shipment requirements, ranging from as low as -20˚C to as high as 25˚C.
IAG Cargo’s global Constant Climate network now totals 110 Quality Approved Stations around the world, making it one of the most comprehensive offerings of its kind. IAG Cargo was also the first carrier to have been awarded Wholesale Distribution Authorisation and Good Distribution Practice Certificate for medicines by a national authority, the UK Medicines and Healthcare Regulatory Agency.
Alan Dorling, Global Head of Pharmaceuticals & Life Sciences at IAG Cargo, said: “Since opening our first Constant Climate centre in 2006, we’ve worked closely with our freight forwarding and pharmaceutical shippers to continually develop the quality of our product service. We’ve transported critical vaccines at times of pandemic and we are continually entrusted with high value temperature-sensitive medicines, such as insulin and oncology drugs.
“Our extensive network of 110 Constant Climate centres offers the speed and care required when transporting pharmaceutical products. We deliver unrivalled support to freight forwarders and shippers in this extremely technical sector and expect to grow even further over the coming years."
The anniversary follows the opening in December 2015 of two new Constant Climate stations in Latin America, bringing the total number of stations in the region to 18, and making it one of the largest regional networks for the transportation of time and temperature-sensitive pharmaceuticals.
